Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion.
Cimino I, Casoni F, Liu X, Messina A, Parkash J, Jamin SP, Catteau-Jonard S, Collier F, Baroncini M, Dewailly D, Pigny P, Prescott M, Campbell R, Herbison AE, Prevot V, Giacobini P. · 2016
Read Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. by Cimino I, Casoni F, Liu X, Messina A, Parkash J, Jamin SP, Catteau-Jonard S, Collier F, Baroncini M, Dewailly D, Pigny P, Prescott M, Campbell R, Herbison AE, Prevot V, Giacobini P. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4729924.txt.
Introduction
Irene Cimino, Filippo Casoni, Xinhuai Liu, and a large team found a brain role for anti-Müllerian hormone, in Nature Communications in 2016. The hormone is known for shaping sex development and ovary function. Whether it also acts in the brain was unexplored. The team showed that many GnRH neurons, the master cells of reproduction, carry its receptor, in both mice and humans. In mice the hormone switched those neurons on strongly.
Firing rose, and the downstream hormone LH came in stronger pulses. That pattern matters clinically: fast LH pulses are a hallmark of polycystic ovary syndrome, the commonest cause of female infertility, where this hormone's blood levels also run high. The authors raise the possibility that excess hormone overstimulates the brain's reproductive command cells in that syndrome. If so, calming that signal could become a treatment idea, a fresh angle on a stubborn condition.
Catalog record
| CREATOR | Cimino I, Casoni F, Liu X, Messina A, Parkash J, Jamin SP, Catteau-Jonard S, Collier F, Baroncini M, Dewailly D, Pigny P, Prescott M, Campbell R, Herbison AE, Prevot V, Giacobini P. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion By Irene Cimino, Filippo Casoni, Xinhuai Liu, Andrea Messina, Jyoti Parkash, Soazik P. Jamin, Sophie Catteau-Jonard, Francis Collier, Marc Baroncini, Didier Dewailly, Pascal Pigny, Mel Prescott Published in: Nature Communications DOI: 10.1038/ncomms10055 ABSTRACT Anti-Müllerian hormone (AMH) plays crucial roles in sexual differentiation and gonadal functions. However, the possible extragonadal effects of AMH on the hypothalamic–pituitary–gonadal axis remain unexplored. Here we demonstrate that a significant subset of GnRH neurons both in mice and humans express the AMH receptor, and that AMH potently activates the GnRH neuron firing in mice. Combining in vivo and in vitro experiments, we show that AMH increases GnRH-dependent LH pulsatility and secretion, supporting a central action of AMH on GnRH neurons. Increased LH pulsatility is an important pathophysiological feature in many cases of polycystic ovary syndrome (PCOS), the most common cause of female infertility, in which circulating AMH levels are also often elevated. However, the origin of this dysregulation remains unknown. Our findings raise the intriguing hypothesis that AMH-dependent regulation of GnRH release could be involved in the pathophysiology of fertility and could hold therapeutic potential for treating PCOS. Reproduction in mammals is dependent on the function of specific neurons that secrete GnRH. These neurons send projections to the median eminence (ME) of the hypothalamus, which serves as an interface between the neural and peripheral endocrine systems. Here GnRH is released into the pituitary portal blood vessels for delivery to the anterior pituitary to elicit the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH)1. Alterations in the development of this system or in the secretion of GnRH are associated with a number of reproductive disorders including hypogonadotropic hypogonadism, hypothalamic amenorrhoea, hyperprolactinemia and polycystic ovary syndrome (PCOS)23. PCOS is a common complex endocrinopathy that occurs in up to 10% of women45. A hallmark of PCOS is increased LH concentrations and LH:FSH ratios6. Among the heterogeneity of symptoms in PCOS women, it is still not clear why the GnRH-induced LH level is altered. In PCOS women, anti-Müllerian hormone (AMH) is suspected to play a significant role in causing anovulation due to its inhibitory influence on FSH that normally promotes follicular development from the small antral stage to ovulation stage789. Moreover, previous studies have shown that plasma AMH levels in PCOS patients are two- to threefold higher than in women with normal ovaries1011, and that the severity of the PCOS phenotype correlates with AMH production, which is higher in anovulatory than in ovulatory PCOS patients1213. AMH, also known as Müllerian-inhibiting substance, is a member of the transforming growth factor-β (TGF-β) superfamily14. It is a homodimeric glycoprotein with a molecular weight of 140 kDa, in which the two monomers are linked by disulfide bonds14. In females, AMH is secreted by ovarian granulosa cells15 and appears to regulate the early transition from resting primordial follicles to growing follicles16. AMH signals by binding to a specific type-II receptor (AMHR2)1718 that heterodimerizes with one of several type-I receptors (ALK2, ALK3 and ALK6), and recruiting Smad proteins that are translocated to the nucleus to regulate target gene expression19. AMH is the only known ligand of AMHR2, suggesting that tissues that express this receptor are likely to be targets of AMH. In females, the distribution and function of AMHR2 have not been extensively studied beyond its role in the ovaries, despite its expression in extragonadal tissues including the developing brain2021. Here we show that AMH induces LH secretion by stimulating the activity of the hypothalamic GnRH neurons, which express AMH receptors in vivo both in mice and in humans. These data pinpoint AMH as an important regulator of the GnRH system, opening new avenues for the study of AMH signalling in reproductive function and dysfunction. RESULTS AMHR2 expression in the brain and in GnRH neurons We first examined the expression of AMHR2 protein in the adult brain of AMHR2 wild-type and null mice (AMHR2::Cre)22 by labelling the brain sections from postnatal day 90 (P90) female mice with two different antisera to AMHR2: an affinity-purified custom-made rabbit polyclonal antiserum directed against an intracellular epitope (Fig. 1a–l) and a commercial goat polyclonal antiserum directed against an extracellular region of the receptor (Fig. 1m–p). AMHR2-immunoreactive cells were widely distributed in several brain regions including the cortex (Fig. 1a,i,m), hippocampus (Fig. 1a,k,o) and hypothalamus where GnRH cell bodies and fibres are located (Fig. 1c,e,f). Immunohistochemical analysis in AMHR2-null mouse brains revealed the lack of AMHR2 immunoreactivity (Fig. 1b,d,g,j,l,n,p), confirming the specificity of both antibodies. Moreover, we detected AMHR2-Cre activity using the Z/EG23 mouse reporter line (Fig. 1h) in the same AMHR2-immunopositive territories. Interestingly, AMHR2 expression was detected in two non-neuronal cell types in the ME that regulate neurohormone secretion by interacting closely with GnRH terminals in this region24: endothelial cells and specialized hypothalamic glia called tanycytes (Fig. 1f,h). To determine whether GnRH neurons express AMHR2 during their development and maturation, double-immunofluorescence experiments were performed on the sections of mouse (Fig. 2a–c) and human fetuses (Fig. 2j–m), as well as on the hypothalamic sections from adult female mice (Fig. 2d–i) and humans (Fig. 2n–p). We found that in both species, AMHR2 was expressed in GnRH neurons in early embryonic development as well as in adulthood. In adult mice (Fig. 2d–i) and humans (Fig. 2n–p), double immunolabelling revealed that AMHR2 continued to be expressed by >50% of the GnRH neurons located in the sections containing the preoptic region (POA), including the organum vasculosum of the lamina terminalis, as well as in more rostral areas such as in the septum and in the diagonal band of Broca (Supplementary Fig. 1). We next took advantage of GnRH::GFP25 mice to isolate green fluorescent protein (GFP)-positive GnRH neurons at different developmental stages by fluorescence-activated cell sorting (FACS)26 (Fig. 3a) and used quantitative reverse transcription–PCR (RT–PCR) to analyse the expression of genes of interest in these neurons. At embryonic day 12.5 (E12.5), when most GnRH neurons are still located in the nasal region, where they are born2728, AMHR2 expression was low. However, in the hypothalamic/preoptic area of juvenile (postnatal day 12; P12) and adult female mice (P90), in which GnRH neurons have completed their migration into the brain, AMHR2 transcript levels were significantly increased (Fig. 3b). In addition, mature GnRH neurons expressed the three ALK receptors (Fig. 3c). We then confirmed by immunocytochemistry the AMHR2 protein expression in fully differentiated primary GnRH::GFP neurons2930, using an antibody directed against the extracellular region of the receptor (Fig. 3d–f). AMH regulates GnRH neuron excitability and secretion To determine whether AMH acts predominantly at GnRH cell bodies or terminals or both, we investigated the effect of AMH on GnRH neuron firing activity and GnRH secretion in brain slices containing GnRH somata or terminals, respectively. We first performed electrophysiological recordings of GnRH neurons in acute brain-slice preparations containing the POA of GnRH::GFP mice. AMH at 0.04, 0.4 and 4 nM (equivalent to 1, 10 and 100 ng ml−1 of recombinant AMH, homodimeric active form) concentrations was tested on GnRH-GFP neuronal cell bodies located in the POA by bath application. These concentrations are in the physiological range of serum AMH that was previously reported to be ∼0.1 nM (for the 140-kDa homodimeric precursor) in 4–8-month-old female mice31.